U.S. Securities and Exchange Commission (SEC)
Official Release: https://www.sec.gov/files/litigation/admin/2026/34-106289.pdf
NEWS:
The SEC's September 8, 2026 order, Release No. 34-106289, names CuraScientific Corp. as the respondent in a proceeding under Section 12(j) of the Securities Exchange Act. The order identifies CuraScientific as a Florida corporation located in Grass Valley, California, with securities registered under Section 12(g). It states that the company's last periodic report was its Form 10-Q for the period ended September 30, 2023.
The Division of Enforcement alleges that CuraScientific repeatedly failed to meet its filing obligations and did not heed a delinquency letter requesting compliance—or may not have received it because the company failed to maintain a valid address on file with the SEC. The order says unsolicited quotations for its common stock, ticker CSTF, are submitted on OTC Link ATS.
The order begins a fact-finding proceeding and allows the company to answer the allegations and present defenses. The SEC will determine whether suspension of the securities' registration for up to 12 months or revocation is appropriate. The proceeding is not a final finding of liability.
KEY POINTS:
- SEC Release No. 34-106289, administrative file No. 3-22710, is dated September 8, 2026.
- The SEC alleges CuraScientific has not filed periodic reports since its September 30, 2023 Form 10-Q.
- The order lists the company as a Florida corporation based in Grass Valley, California; its ticker is CSTF.
- The alleged violations involve Exchange Act Section 13(a) and Rules 13a-1 and 13a-13.
- Possible outcomes include suspension for up to 12 months or revocation of the securities' registration; the proceeding remains pending.